TRI and MCC Integrate RBM Tools
The solution will ‘hand-hold’ companies through the process of performing a protocol risk assessment and developing resulting quality risk management plan.
Following a long-standing working relationship between Triumph Research Intelligence (TRI) and the Metrics Champion Consortium (MCC), TRI will make MCC’s Risk Assessment and Mitigation Management Tool (RAMMT) available as part of the risk assessment and management module in its OPRA Risk-Based Monitoring and Quality Management platform. The OPRA solution will ‘hand-hold’ companies through the process of performing a protocol risk assessment and developing resulting quality risk management plan in a centrally accessible, cloud based application, and provide the guidance which comes from the MCC’s RAMMT content at the same time.
Read the full
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- NIMBLE Trial Reveals New Insights on Complement Inhibition in gMG
September 15th 2025
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025